Laparoscopic sleeve gastrectomy for super obese patients

Forty-eight percent excess weight loss after 6 to 8 years with 93% follow-up

George M. Eid, Stacy Brethauer, Samer G. Mattar, Rebecca L. Titchner, William Gourash, Philip R. Schauer

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

OBJECTIVES: In this study, we report long-term outcomes of high-risk, high-BMI (body mass index) patients who underwent laparoscopic sleeve gastrectomy (LSG). BACKGROUND: Short- and medium-term data appear to support the effectiveness of LSG, but long-term data to support its durability are sparse. METHODS: A prospective database was reviewed on all high-risk patients who underwent LSG as part of a staged approach for surgical treatment of severe obesity between January 2002 and February 2004. We included only patients who did not proceed to second-stage surgery (gastric bypass). Analyzed data included demographics, BMI, comorbidities, and surgical outcomes. All partial gastrectomies were performed using a 50F bougie. RESULTS: Seventy-four patients underwent LSG, and follow-up data were available on 69 of 74 patients (93%). The mean age was 50 years (25-78) and the mean number of co-morbidities was 9.6. Perioperative mortality (<30 days) was zero, and the incidence of short- and long-term postoperative complications was 15%. The mean overall follow-up time period was 73 months (38-95). Mean excess weight loss (EWL) at 72, 84, and 96 months after LSG was 52%, 43%, and 46%, respectively, with an overall EWL of 48%. The mean BMI decreased from 66 kg/m(43-90) to 46 kg/m (22-73). Seventy-seven percent of the diabetic patients showed improvement or remission of the disease. CONCLUSIONS: This study reports the longest follow-up of LSG patients thus far and supports the effectiveness, safety, and durability of laparoscopic sleeve gastrectomy as a definitive therapeutic option for severe obesity, even in high-risk, high-BMI patients.

Original languageEnglish
Pages (from-to)262-265
Number of pages4
JournalAnnals of Surgery
Volume256
Issue number2
DOIs
StatePublished - Aug 2012

Fingerprint

Gastrectomy
Weight Loss
Morbid Obesity
Gastric Bypass
Comorbidity
Body Mass Index
Demography
Databases
Morbidity
Safety
Mortality
Incidence
Therapeutics

Keywords

  • bariatric surgery
  • high risk
  • morbid obesity
  • sleeve gastrectomy

ASJC Scopus subject areas

  • Surgery

Cite this

Laparoscopic sleeve gastrectomy for super obese patients : Forty-eight percent excess weight loss after 6 to 8 years with 93% follow-up. / Eid, George M.; Brethauer, Stacy; Mattar, Samer G.; Titchner, Rebecca L.; Gourash, William; Schauer, Philip R.

In: Annals of Surgery, Vol. 256, No. 2, 08.2012, p. 262-265.

Research output: Contribution to journalArticle

Eid, George M. ; Brethauer, Stacy ; Mattar, Samer G. ; Titchner, Rebecca L. ; Gourash, William ; Schauer, Philip R. / Laparoscopic sleeve gastrectomy for super obese patients : Forty-eight percent excess weight loss after 6 to 8 years with 93% follow-up. In: Annals of Surgery. 2012 ; Vol. 256, No. 2. pp. 262-265.
@article{82459f37574240e595a11a935ef29f64,
title = "Laparoscopic sleeve gastrectomy for super obese patients: Forty-eight percent excess weight loss after 6 to 8 years with 93{\%} follow-up",
abstract = "OBJECTIVES: In this study, we report long-term outcomes of high-risk, high-BMI (body mass index) patients who underwent laparoscopic sleeve gastrectomy (LSG). BACKGROUND: Short- and medium-term data appear to support the effectiveness of LSG, but long-term data to support its durability are sparse. METHODS: A prospective database was reviewed on all high-risk patients who underwent LSG as part of a staged approach for surgical treatment of severe obesity between January 2002 and February 2004. We included only patients who did not proceed to second-stage surgery (gastric bypass). Analyzed data included demographics, BMI, comorbidities, and surgical outcomes. All partial gastrectomies were performed using a 50F bougie. RESULTS: Seventy-four patients underwent LSG, and follow-up data were available on 69 of 74 patients (93{\%}). The mean age was 50 years (25-78) and the mean number of co-morbidities was 9.6. Perioperative mortality (<30 days) was zero, and the incidence of short- and long-term postoperative complications was 15{\%}. The mean overall follow-up time period was 73 months (38-95). Mean excess weight loss (EWL) at 72, 84, and 96 months after LSG was 52{\%}, 43{\%}, and 46{\%}, respectively, with an overall EWL of 48{\%}. The mean BMI decreased from 66 kg/m(43-90) to 46 kg/m (22-73). Seventy-seven percent of the diabetic patients showed improvement or remission of the disease. CONCLUSIONS: This study reports the longest follow-up of LSG patients thus far and supports the effectiveness, safety, and durability of laparoscopic sleeve gastrectomy as a definitive therapeutic option for severe obesity, even in high-risk, high-BMI patients.",
keywords = "bariatric surgery, high risk, morbid obesity, sleeve gastrectomy",
author = "Eid, {George M.} and Stacy Brethauer and Mattar, {Samer G.} and Titchner, {Rebecca L.} and William Gourash and Schauer, {Philip R.}",
year = "2012",
month = "8",
doi = "10.1097/SLA.0b013e31825fe905",
language = "English",
volume = "256",
pages = "262--265",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Laparoscopic sleeve gastrectomy for super obese patients

T2 - Forty-eight percent excess weight loss after 6 to 8 years with 93% follow-up

AU - Eid, George M.

AU - Brethauer, Stacy

AU - Mattar, Samer G.

AU - Titchner, Rebecca L.

AU - Gourash, William

AU - Schauer, Philip R.

PY - 2012/8

Y1 - 2012/8

N2 - OBJECTIVES: In this study, we report long-term outcomes of high-risk, high-BMI (body mass index) patients who underwent laparoscopic sleeve gastrectomy (LSG). BACKGROUND: Short- and medium-term data appear to support the effectiveness of LSG, but long-term data to support its durability are sparse. METHODS: A prospective database was reviewed on all high-risk patients who underwent LSG as part of a staged approach for surgical treatment of severe obesity between January 2002 and February 2004. We included only patients who did not proceed to second-stage surgery (gastric bypass). Analyzed data included demographics, BMI, comorbidities, and surgical outcomes. All partial gastrectomies were performed using a 50F bougie. RESULTS: Seventy-four patients underwent LSG, and follow-up data were available on 69 of 74 patients (93%). The mean age was 50 years (25-78) and the mean number of co-morbidities was 9.6. Perioperative mortality (<30 days) was zero, and the incidence of short- and long-term postoperative complications was 15%. The mean overall follow-up time period was 73 months (38-95). Mean excess weight loss (EWL) at 72, 84, and 96 months after LSG was 52%, 43%, and 46%, respectively, with an overall EWL of 48%. The mean BMI decreased from 66 kg/m(43-90) to 46 kg/m (22-73). Seventy-seven percent of the diabetic patients showed improvement or remission of the disease. CONCLUSIONS: This study reports the longest follow-up of LSG patients thus far and supports the effectiveness, safety, and durability of laparoscopic sleeve gastrectomy as a definitive therapeutic option for severe obesity, even in high-risk, high-BMI patients.

AB - OBJECTIVES: In this study, we report long-term outcomes of high-risk, high-BMI (body mass index) patients who underwent laparoscopic sleeve gastrectomy (LSG). BACKGROUND: Short- and medium-term data appear to support the effectiveness of LSG, but long-term data to support its durability are sparse. METHODS: A prospective database was reviewed on all high-risk patients who underwent LSG as part of a staged approach for surgical treatment of severe obesity between January 2002 and February 2004. We included only patients who did not proceed to second-stage surgery (gastric bypass). Analyzed data included demographics, BMI, comorbidities, and surgical outcomes. All partial gastrectomies were performed using a 50F bougie. RESULTS: Seventy-four patients underwent LSG, and follow-up data were available on 69 of 74 patients (93%). The mean age was 50 years (25-78) and the mean number of co-morbidities was 9.6. Perioperative mortality (<30 days) was zero, and the incidence of short- and long-term postoperative complications was 15%. The mean overall follow-up time period was 73 months (38-95). Mean excess weight loss (EWL) at 72, 84, and 96 months after LSG was 52%, 43%, and 46%, respectively, with an overall EWL of 48%. The mean BMI decreased from 66 kg/m(43-90) to 46 kg/m (22-73). Seventy-seven percent of the diabetic patients showed improvement or remission of the disease. CONCLUSIONS: This study reports the longest follow-up of LSG patients thus far and supports the effectiveness, safety, and durability of laparoscopic sleeve gastrectomy as a definitive therapeutic option for severe obesity, even in high-risk, high-BMI patients.

KW - bariatric surgery

KW - high risk

KW - morbid obesity

KW - sleeve gastrectomy

UR - http://www.scopus.com/inward/record.url?scp=84863830186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863830186&partnerID=8YFLogxK

U2 - 10.1097/SLA.0b013e31825fe905

DO - 10.1097/SLA.0b013e31825fe905

M3 - Article

VL - 256

SP - 262

EP - 265

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 2

ER -